Showing results (191-200 of 398) with videos related to

Sort By:
Pageof 40
International Journal of Colorectal Disease|July 18, 2009
A phase I trial of S-1 with oxaliplatin in patients with relapsed and metastatic colorectal cancerHyeong Su Kim, Min Jae Park, Ji Eun Uhm, et al.
Frontiers in Oncology|December 19, 2019
Systematic Evaluation of Gastric Tumor Cell Index and Two-Drug Combination Therapy via 3-Dimensional High-Throughput Drug ScreeningSung Hee Lim, Jason K Sa, Dong Woo Lee, et al.
European Journal of Cancer (Oxford, England : 1990)|September 15, 2014
Simvastatin plus capecitabine-cisplatin versus placebo plus capecitabine-cisplatin in patients with previously untreated advanced gastric cancer: a double-blind randomised phase 3 studySeung Tae Kim, Jung Hun Kang, Jeeyun Lee, et al.
The Korean Journal of Internal Medicine|January 16, 2015
The efficacy of low-dose transdermal fentanyl in opioid-naïve cancer patients with moderate-to-severe painJung Hun Kang, Sung Yong Oh, Seo-Young Song, et al.
Cancer Chemotherapy and Pharmacology|March 28, 2016
Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinomaYoung Saing Kim, In Gyu Hwang, Song-Ee Park, et al.
Cancer Chemotherapy and Pharmacology|May 22, 2013
Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasisJun Ho Ji, Se Hoon Park, Jeeyun Lee, et al.
Cancer Chemotherapy and Pharmacology|October 29, 2013
Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patientsJung Yong Hong, Eun Mi Nam, Jeeyun Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 28, 2016
FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survivalSoomin Ahn, Jeeyun Lee, Mineui Hong, et al.
Investigational New Drugs|April 10, 2017
Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumorsSu Jin Lee, Seon Young Lee, Weon Sup Lee, et al.
Oncotarget|January 12, 2017
Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instabilityJunhun Cho, Jeeyun Lee, Heejin Bang, et al.
Pageof 40